Surface Logix, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Surface Logix, Inc. - overview
Established
1999
Location
Brighton, MA, US
Primary Industry
Pharmaceuticals
About
Founded in 1999, Surface Logix, Inc. , is a drug development company, which creates and develops small molecule drugs to treat metabolic and cardiovascular diseases.
Current Investors
ARCH Venture Partners, TIAA-CREF Life Insurance Company, Intel Capital
Primary Industry
Pharmaceuticals
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Cardiology, Pharmaceutical Research & Development, Specialty Pharmaceuticals
Website
www.surfacelogix.com
Verticals
HealthTech
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Surface Logix, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.